Repurposing Metoprolol as COVID-19-Associated ARDS Treatment May Be ‘Safe and Inexpensive’ Strategy – MADRID-COVID Researchers
Repurposing the “clinically available and cheap drug” metoprolol for COVID-19-associated acute respiratory distress syndrome (ARDS) “appears to be a safe and inexpensive strategy” to reduce the burden of the ongoing pandemic, according to MADRID-COVID trial researchers.